KRN7000 analog 1
Product Specifications
UNSPSC Description
KRN7000 analog 1 exhibits good Th1-biased immune response through induction of interferon-γ (IFN-γ) and reduction of interleukin-4 (IL-4). KRN7000 analog 1 is potential as an antitumor agent and vaccine adjuvant[1].
Target Antigen
IFNAR; Interleukin Related
Type
Reference compound
Related Pathways
Immunology/Inflammation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/krn7000-analog-1.html
Smiles
OC[C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]([C@@H]([C@@H](CCCCCCCCCCCCCC)O)O)NC(CCCCCCCCCCC2=CC=C(C=C2)SC3=CC=C(C=C3)F)=O)O)O)O
Molecular Weight
850.17
References & Citations
[1]Hao T, et al. Stereospecific Synthesis and Biological Evaluation of KRN7000 Analogues with Thio-modifications at the Acyl Moiety[J]. ACS Medicinal Chemistry Letters, 2024.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163704/KRN7000-analog-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163704/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items